Literature DB >> 26471120

'Shadow sign' in congenital hypertrophy of the retinal pigment epithelium of young myopic pigmented patients.

M Y Chang1, J B McBeath2, C A McCannel1, T A McCannel1.   

Abstract

PURPOSE Congenital hypertrophy of the retinal pigment epithelium (CHRPE) may simulate choroidal melanoma in certain cases. We report unique clinical features we have observed in cases of CHRPE in young myopic pigmented patients.METHODS Patients who were referred for evaluation of a suspicious choroidal lesion and found to have a CHRPE lesion with the clinical appearance of lesion elevation and a subretinal fluid-like 'shadow sign' were included. Patient and lesion characteristics were tabulated. Available images, including fundus photography, ultrasonography, optical coherence tomography (OCT), and fluorescein angiography (FA) were reviewed.ResultsSix patients were included. The 'shadow sign' was anterior to the CHRPE lesion in all cases. The mean age of the patients was 27.3 years. The ethnicities of the patients were Chinese (n=1), Hispanic (n=3), or African-American (n=2). Five of six patients were myopic.CONCLUSIONS Although most CHRPE lesions appear flat on ophthalmoscopy, lesions in young myopic patients of pigmented ethnicities may appear elevated with a 'shadow sign' due to 'dark without pressure.' This new finding may be related to the vitreoretinal interface in young myopic pigmented patients and must be distinguished from true subretinal fluid and lesion thickness, which are often observed in choroidal melanoma.

Entities:  

Mesh:

Year:  2015        PMID: 26471120      PMCID: PMC4709533          DOI: 10.1038/eye.2015.187

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Dark-without-pressure fundus lesions.

Authors:  K C Nagpal; M F Goldberg; G Asdourian; M Goldbaum; F Huamonte
Journal:  Br J Ophthalmol       Date:  1975-09       Impact factor: 4.638

2.  The ophtalmoscopic sign "white with pressure". A clinicopathologic correlation.

Authors:  R C WATZKE
Journal:  Arch Ophthalmol       Date:  1961-12

3.  Vitreous changes in high myopia observed by swept-source optical coherence tomography.

Authors:  Hirotaka Itakura; Shoji Kishi; Danjie Li; Keisuke Nitta; Hideo Akiyama
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-10       Impact factor: 4.799

4.  Multimodal imaging of white and dark without pressure fundus lesions.

Authors:  Amani A Fawzi; Jared S Nielsen; Aranzazu Mateo-Montoya; Thanapong Somkijrungroj; Helen K Li; John Gonzales; Martine Mauget-Faÿsse; Lee M Jampol
Journal:  Retina       Date:  2014-12       Impact factor: 4.256

5.  Congenital hypertrophy of the retinal pigment epithelium.

Authors:  H Buettner
Journal:  Am J Ophthalmol       Date:  1975-02       Impact factor: 5.258

6.  Prevalence of posterior vitreous detachment in high myopia.

Authors:  J Akiba
Journal:  Ophthalmology       Date:  1993-09       Impact factor: 12.079

7.  A clinical study of the development of posterior vitreous detachment in high myopia.

Authors:  H Morita; M Funata; T Tokoro
Journal:  Retina       Date:  1995       Impact factor: 4.256

8.  Solitary congenital hypertrophy of the retinal pigment epithelium: clinical features and frequency of enlargement in 330 patients.

Authors:  Carol L Shields; Arman Mashayekhi; Thucanh Ho; Jacqueline Cater; Jerry A Shields
Journal:  Ophthalmology       Date:  2003-10       Impact factor: 12.079

  8 in total
  2 in total

1.  Evolving Longitudinal Retinal Observations in a Cohort of Survivors of Ebola Virus Disease.

Authors:  Paul J Steptoe; Fayiah Momorie; Alimamy D Fornah; Patrick Komba; Elizabeth Emsley; Janet T Scott; Samantha J Williams; Simon P Harding; Matthew J Vandy; Foday Sahr; Nicholas A V Beare; Malcolm G Semple
Journal:  JAMA Ophthalmol       Date:  2020-04-01       Impact factor: 7.389

2.  Analysis of White and Dark without Pressure in a Young Myopic Group Based on Ultra-Wide Swept-Source Optical Coherence Tomography Angiography.

Authors:  Huimin Yu; Huan Luo; Xian Zhang; Jinfu Sun; Zheng Zhong; Xufang Sun
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.